PD‐L1 expression in ROS1‐rearranged non‐small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1

BACKGROUND: The aim of the current study was to investigate the prevalence and clinicopathologic characteristics of ROS1‐rearranged non‐small cell lung cancer (NSCLC) in routine genotypic screening in conjunction with the study of PD‐L1 expression, a biomarker for first‐line treatment decisions. MET...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Autores principales: Lee, Jongmin, Park, Chan Kwon, Yoon, Hyoung‐Kyu, Sa, Young Jo, Woo, In Sook, Kim, Hyo Rim, Kim, Sue Youn, Kim, Tae‐Jung
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312846/
https://ncbi.nlm.nih.gov/pubmed/30475455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12917
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares